11. van Hagen IM, Roos-Hesselink JW, Ruys TPE, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardi- ology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015;132:132 42. 12. Goland S, Schwartzenberg S, Fan J, et al. Monitoring of anti-Xa in preg- nant patients with mechanical prosthetic valves receiving low-molecular- weight heparin: peak or trough levels? J Cardiovasc Pharmacol Ther. 2014;19:451 6. 13. Elkayam U. Anticoagulation therapy for pregnant women with mechani- cal prosthetic heart valves: how to improve safety? J Am Coll Cardiol. 2017;69:2692 5. 14. Vause S, Clarke B, Tower CL, et al. Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system. BJOG. 2017;124:1411 9. 15. Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the pro- phylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost. 2004;92:747 51. 16. Steinberg ZL, Dominguez-Islas CP, Otto CM, et al. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves. J Am Coll Cardiol. 2017;69:2681 91. 17. D Souza R, Silversides CK, McLintock C. Optimal anticoagulation for pregnant women with mechanical heart valves. Semin Thromb Hemost. 2016;42:798 804. 18. Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complica- tions of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637 41. 19. Meschengieser SS, Fondevila CG, Santarelli MT, et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart. 1999;82:23 6. 20. Sadler L, McCowan L, White H, et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG. 2000;107:245 53. 21. Horlocker TT, Vandermeuelen E, Kopp SL, et al. 